These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
379 related articles for article (PubMed ID: 15890110)
21. [Expressions of inducible nitric oxide synthase and vascular endothelial growth factor and their relationship with microvessel density in hepatocellular carcinoma]. Xiao G; Zhang WM; Zhang M; Xie D; Guo AL; Wen JM Ai Zheng; 2005 Jan; 24(1):99-103. PubMed ID: 15642211 [TBL] [Abstract][Full Text] [Related]
22. [Overexpression and genomic amplification of decoy receptor 3 in hepatocellular carcinoma and significance thereof]. Shen HW; Wu YL; Peng SY Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):744-7. PubMed ID: 12899749 [TBL] [Abstract][Full Text] [Related]
23. NY-ESO-1 expression and immunogenicity in esophageal cancer. Fujita S; Wada H; Jungbluth AA; Sato S; Nakata T; Noguchi Y; Doki Y; Yasui M; Sugita Y; Yasuda T; Yano M; Ono T; Chen YT; Higashiyama M; Gnjatic S; Old LJ; Nakayama E; Monden M Clin Cancer Res; 2004 Oct; 10(19):6551-8. PubMed ID: 15475443 [TBL] [Abstract][Full Text] [Related]
24. Receptor activator of nuclear factor-kappaB ligand (RANKL) expression in hepatocellular carcinoma with bone metastasis. Sasaki A; Ishikawa K; Haraguchi N; Inoue H; Ishio T; Shibata K; Ohta M; Kitano S; Mori M Ann Surg Oncol; 2007 Mar; 14(3):1191-9. PubMed ID: 17195907 [TBL] [Abstract][Full Text] [Related]
25. Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features. Grah J; Samija M; Juretić A; Sarcević B; Sobat H Coll Antropol; 2008 Sep; 32(3):731-6. PubMed ID: 18982744 [TBL] [Abstract][Full Text] [Related]
26. [Correlation of perioperative alpha-fetoprotein expression in peripheral blood to recurrence of hepatocellular carcinoma]. Shi M; Zhang Y; Zhong C; Lin XJ; Zhang CQ; Li JQ Ai Zheng; 2008 Jan; 27(1):83-7. PubMed ID: 18184471 [TBL] [Abstract][Full Text] [Related]
27. [Expression and clinical significance of hepatocellular cancer antigen genes in human hepatocellular carcinoma]. Wang WX; Leng XS; Peng JR; Mu DC; Wang Y; Zhu JY; Du RY; Chen WF Zhonghua Wai Ke Za Zhi; 2003 Jul; 41(7):506-8. PubMed ID: 12921655 [TBL] [Abstract][Full Text] [Related]
29. Expression of cancer/testis (CT) antigens in Chinese hepatocellular carcinoma and its correlation with clinical parameters. Peng JR; Chen HS; Mou DC; Cao J; Cong X; Qin LL; Wei L; Leng XS; Wang Y; Chen WF Cancer Lett; 2005 Mar; 219(2):223-32. PubMed ID: 15723723 [TBL] [Abstract][Full Text] [Related]
30. Detection of MAGE-1, MAGE-3 and AFP mRNA as multimarker by real-time quantitative PCR assay: a possible predictor of hematogenous micrometastasis of hepatocellular carcinoma. Zhang Y; Li Q; Liu N; Song T; Liu Z; Guo R; Meng L Hepatogastroenterology; 2008; 55(88):2200-6. PubMed ID: 19260505 [TBL] [Abstract][Full Text] [Related]
31. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma. Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339 [TBL] [Abstract][Full Text] [Related]
32. [Melanoma antigen-3 expression in human hepatocellular carcinoma]. Cai S; Zhao H; Leng X; Cheng J; Gong S; Peng J; Cong X; Wang Y; Rui J; Hui Y; Du R; Chen W Zhonghua Wai Ke Za Zhi; 2000 Sep; 38(9):693-6. PubMed ID: 11832142 [TBL] [Abstract][Full Text] [Related]
33. [Expression of MAGE-1 gene in hepatocellular carcinoma]. Cai S; Chen H; Wang Y Zhonghua Yi Xue Za Zhi; 1999 Sep; 79(9):668-72. PubMed ID: 11715455 [TBL] [Abstract][Full Text] [Related]
34. Ny-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: correlation with tumor grade. Kurashige T; Noguchi Y; Saika T; Ono T; Nagata Y; Jungbluth A; Ritter G; Chen YT; Stockert E; Tsushima T; Kumon H; Old LJ; Nakayama E Cancer Res; 2001 Jun; 61(12):4671-4. PubMed ID: 11406534 [TBL] [Abstract][Full Text] [Related]
35. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma]. Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653 [TBL] [Abstract][Full Text] [Related]
36. [Detection of alpha-fetoproteins mRNA and melanoma antigen-1 mRNA in peripheral blood of patients with hepatocellular carcinoma and its clinical significance]. Yang SZ; Dong JH; Zhu J; Li K; Zhang Y Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(17):1060-3. PubMed ID: 15498320 [TBL] [Abstract][Full Text] [Related]
37. [Expression of tumor-specific cancer/testis antigens in hepatocellular carcinoma]. Chen HS; Qin LL; Cong X; Wang Y; Fei R; Jiang D; Cao J; Su JJ; Wei L; Chen WF; Wang Y Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):145-8. PubMed ID: 12681059 [TBL] [Abstract][Full Text] [Related]
38. AFP mRNA detected in bone marrow by real-time quantitative RT-PCR analysis predicts survival and recurrence after curative hepatectomy for hepatocellular carcinoma. Kamiyama T; Takahashi M; Nakagawa T; Nakanishi K; Kamachi H; Suzuki T; Shimamura T; Taniguchi M; Ozaki M; Matsushita M; Furukawa H; Todo S Ann Surg; 2006 Sep; 244(3):451-63. PubMed ID: 16926571 [TBL] [Abstract][Full Text] [Related]
39. [Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma]. Moon JI; Kim JM; Jung GO; Chun JM; Choi GS; Park JB; Kwon CH; Kim SJ; Jo JW Korean J Hepatol; 2008 Jun; 14(2):185-96. PubMed ID: 18617766 [TBL] [Abstract][Full Text] [Related]
40. Detection of AFPmRNA and melanoma antigen gene-1mRNA as markers of disseminated hepatocellular carcinoma cells in blood. Yang SZ; Dong JH; Li K; Zhang Y; Zhu J Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):227-33. PubMed ID: 15908320 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]